Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PSMB9 |
| Upstream (Parents) |
|---|
| (<<) CXCL10 → PSMB9 |
| (<<) DDX60 → PSMB9 |
| (<<) BTN3A3 → PSMB9 |
| (<<) HLA-DMA → PSMB9 |
| (<<) UBE2L6 → PSMB9 |
| (<<) TAP1 → PSMB9 |
| (<<) HLA-F → PSMB9 |
| (<<) HLA-C → PSMB9 |
| Downstream (Children) |
|---|
| PSMB9 → DLX2 (>>) |
| PSMB9 → POU6F2 (>>) |
| PSMB9 → UBD///GABBR1 (>>) |
| PSMB9 → AIM2 (>>) |
| PSMB9 → CXCR3 (>>) |
| PSMB9 → CASP1 (>>) |
| PSMB9 → IL15 (>>) |
| PSMB9 → HCP5 (>>) |
| PSMB9 → HCG26 (>>) |
| PSMB9 → MYL7 (>>) |
| PSMB9 → SECTM1 (>>) |
| PSMB9 → TAP1 (>>) |
| PSMB9 → HLA-F (>>) |
| PSMB9 → HLA-C (>>) |
